SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-027769
Filing Date
2020-02-07
Accepted
2020-02-07 11:46:16
Documents
71
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d842208d10q.htm   iXBRL 10-Q 1474582
2 EX-10.1 d842208dex101.htm EX-10.1 20794
3 EX-31.1 d842208dex311.htm EX-31.1 10219
4 EX-31.2 d842208dex312.htm EX-31.2 10272
5 EX-32 d842208dex32.htm EX-32 4517
11 GRAPHIC g842208g0201074711308.jpg GRAPHIC 3894
12 GRAPHIC g842208snap0001.jpg GRAPHIC 6078
  Complete submission text file 0001193125-20-027769.txt   6947480

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vivo-20191231.xsd EX-101.SCH 43141
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20191231_cal.xml EX-101.CAL 50485
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20191231_def.xml EX-101.DEF 226784
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20191231_lab.xml EX-101.LAB 368335
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20191231_pre.xml EX-101.PRE 321717
48 EXTRACTED XBRL INSTANCE DOCUMENT d842208d10q_htm.xml XML 1485136
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 20586082
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences